Effect of Hepatitis C Drugs on Blood Coagulability in Patients on Warfarin Using the Medical Information Database Network (MID-NET(®)) in Japan

BACKGROUND: Previous studies suggested that direct-acting antivirals (DAAs) against hepatitis C increased the blood coagulability of patients on warfarin. This study aims to descriptively investigate the effects of DAAs on the blood coagulability and liver function of patients on warfarin in Japan....

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Sono, Ando, Takashi, Hirano, Mai, Komiyama, Noriyuki, Iguchi, Toyotaka, Oniyama, Yukio, Ishiguro, Chieko, Uyama, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021533/
https://www.ncbi.nlm.nih.gov/pubmed/33393016
http://dx.doi.org/10.1007/s43441-020-00247-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021533/
https://www.ncbi.nlm.nih.gov/pubmed/33393016
http://dx.doi.org/10.1007/s43441-020-00247-8

Ejemplares similares